Clinical outcomes of modified transarterial chemoembolization vs. drug-eluting bead transarterial chemoembolization as initial treatment for single hepatocellular carcinoma: a propensity score matching analysis
Boyang Chang, Churen Zhou, Chengcheng Liu, Luwen Mu, Mingsheng Huang, Mingjun Bai · 2024
Read Clinical outcomes of modified transarterial chemoembolization vs. drug-eluting bead transarterial chemoembolization as initial treatment for single hepatocellular carcinoma: a propensity score matching analysis by Boyang Chang, Churen Zhou, Chengcheng Liu, Luwen Mu, Mingsheng Huang, Mingjun Bai (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11539394.txt.
Description
Boyang Chang and co-authors compare two artery-delivered chemo methods for a single liver tumor, in a 2024 study. Both methods send drugs through the artery feeding the tumor, a treatment called chemoembolization. One blends an oily drug mix with drug-carrying beads. The other uses beads alone. Patients were matched so the two groups started alike.
The blended method won on several early measures. More patients had their tumor fully respond at first check. They also needed fewer repeat sessions in the first six months. Local regrowth came later and less often with the blend. Patients who fully responded to the blend also lived longer. Harms and side effects were tracked for both routes as well.
Catalog record
| CREATOR | Boyang Chang, Churen Zhou, Chengcheng Liu, Luwen Mu, Mingsheng Huang, Mingjun Bai |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |